Royal Biologics Launches MAXX-BMC Bone Marrow Aspirate Concentration System

Royal Biologics announced FDA 510(k) clearance and U.S. launch of MAXX™-BMC. MAXX-BMC is a bone marrow aspirate concentration system that provides users with an optimal sample of concentrated bone marrow aspirate from a patient at point of care. Royal's "Lead Screw" technology in their Maxx concentration device allows users to develop a...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us